Clinical Studies

Diagnostic Clinical Studies
 
The clinical landscape of effectively dealing with various disease states is continually changing as scientists and researchers discover new patient care pathways. Learn about the key clinical studies and trends emerging around the world as physicians try to improve patient outcomes and overall population health.
Disclaimer:Scientific articles are presented for educational purposes only and are not intended to promote any Beckman Coulter product or service. Opinions and conclusions are those of the respective authors and not Beckman Coulter. Beckman Coulter did not provide funding for these studies.
 

Clinical Studies

Aiming to Close the Knowledge Gap

Learn about new key diagnostic clinical studies for important disease states like COVID-19 and sepsis.

Chemistry
Study Shows Differences in the 3 FLC Assays Can = Clinically Different Results

1049-Homepage-icon-200x200

Immunoassay
Study of 1,049 patients excludes AMI 3 hours after ED presentation with hsTnI

Circle-Icon-July-4

Hematology
Study establishes age-and sex-specific pediatric reference intervals for 47 hematologic parameters


1,020 COVID-19-positive patients: higher hs-cTnI levels = higher rates of mechanical ventilation

COVID-19
1,020 COVID-19-positive patients: higher hs-cTnI levels = higher rates of mechanical ventilation

Homepage-Icons-90-percent

COVID-19
Study validates semi-quantitative diagnostic method with 90% sensitivity



Homepage Icons 87.59 percent

Urinalysis
Multi-center study finds 87.59% auto verification pass accurate rate


Trends

Sharing best practices from around the world

Learn about how physicians around the world are tackling important disease states like COVID-19 and sepsis.
Avoiding Unnecessary Administration of Antibiotics

Severe Infection
Avoiding Unnecessary Administration of Antibiotics

Identifying a Decreased Probability of Sepsis Diagnosis

Severe Infection
Identifying a Decreased Probability of Sepsis Diagnosis

Severe Infection
Sepsis Diagnosis: Saving 85 Minutes to Start Abx

Automation
DxA 5000 Reduces TAT in Multiple Sample Types Receiving by a Typical Blood Sciences Lab

October-Trend-Homepage-Icon

Chemistry
Hospital Reduces Average Turnaround Time by 83% with HbA1c Advanced

 

Circle_Icons_Trend-Less-Maintence

Chemistry
Hospital in South Korea improves workflow efficiency with DxC 700 AU

 

Disclaimer: Scientific articles are presented for educational purposes only and are not intended to promote any Beckman Coulter product or service. Opinions and conclusions are those of the respective authors and not Beckman Coulter. Beckman Coulter did not provide funding for these studies.